Insight Molecular Diagnostics Inc.

IPO

Home - iMDx™

Public · Nashville, United States · Founded 2009

Employees
51–200
Founded
2009
Business Model
B2B
Last Round
Venture RoundApr 2026
Rounds
3
Type
Public

About

Insight Molecular Diagnostics Inc. (formerly OncoCyte Corporation) is a precision diagnostics company developing and commercializing molecular tests for transplant monitoring and oncology. Its portfolio includes GraftAssure and VitaGraft for donor-derived cell-free DNA transplant monitoring, and DetermaIO and DetermaCNI for oncology immunotherapy response and treatment monitoring. The company operates a CLIA-accredited laboratory and holds licenses across 49 U.S. states.

Summary

Insight Molecular Diagnostics Inc. is a Healthcare company based in Nashville, United States, founded in 2009. Its most recent funding was a Venture Round round in Apr 2026.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundApr 2026

Sign up to see all 4 rounds

IPO through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Insight Molecular Diagnostics Inc. on Indexed.vc
<a href="https://indexed.vc/companies/insight-molecular-diagnostics-inc"><img src="https://indexed.vc/api/badge/company/insight-molecular-diagnostics-inc" alt="Insight Molecular Diagnostics Inc. on Indexed.vc" width="260" height="76" /></a>